Recombinant human serum albumin (OsrHSA) has emerged as an important innovation in the sphere of biopharmaceuticals, featuring promising improvements throughout numerous health care and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA delivers a safer, more responsible choice for therapeutic use,